ALLIANCE PHARMA plc INVESTMENT

LDG plc

(“LDG”) or the "Company")

Alliance Pharma plc Investment

LDG is pleased to announce that it has acquired 12,845,000 ordinary shares in Alliance Pharma plc ("Alliance") (LON:APH) at an average price of £0.4611 per ordinary share, for a total cash consideration of £5,922,820.

Following these purchases, LDG is interested in approximately 2.38% of Alliance’s issued share capital.

Alliance is an international healthcare group founded in 1996 and headquartered in the United Kingdom. The company acquires, markets, and distributes consumer healthcare and prescription medicine products.

For the year ended 31 December 2021, Alliance reported an underlying pre-tax profit of £42.2 million. As at 30 June 2022, Alliance reported net assets of £296.9 million.

FTI Consulting +44 (0) 20 3727 1340
Nick Hasell
Alex Le May
Cally Billimore

Strand Hanson Limited (Financial and Nominated Adviser) +44 (0) 20 7409 3494
James Spinney
James Dance
Abigail Wennington

Investec Bank plc (Broker) +44 (0) 20 7597 5970
Gary Clarence
Harry Hargreaves